The Prevelence of IVS 1-6 (T-C) [HBB:c.92 +6 T-C] Gene Mutation in Suspected Cases of β Thalassemia in Assiut University Hospitals
Sponsor: Assiut University
Listed as NCT05370677, this observational or N/A phase trial focuses on Beta-Thalassemia and remains ongoing. Sponsored by Assiut University, it has been updated 4 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
4 versions recorded-
Jan 2025 — Present [monthly]
Unknown
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Jan 2025 [monthly]
Not Yet Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting
-
Jun 2022 — Jul 2024 [monthly]
Not Yet Recruiting
First recorded
May 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assiut University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.